Notes
Good ANDA Submission Practices
Manual of Policies and Procedures (MAPP)
Reference
Food and Drug Administration (FDA). Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to facilitate efficient generic drug review to enhance competition, promote access and lower drug prices. Internet Document : 3 Jan 2018. Available from: URL: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm591184.htm
Rights and permissions
About this article
Cite this article
FDA announces new steps to facilitate generic drug reviews. PharmacoEcon Outcomes News 795, 1 (2018). https://doi.org/10.1007/s40274-018-4639-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4639-2